Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

Discover the causes, symptoms, and treatment options for gout—a painful form of arthritis predominantly affecting men.

Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...

According to the World Health Organisation (WHO), over 350 million people globally suffer from arthritis, and despite ...

Healthcare products provider RHEA Generics is committed to promoting affordable healthcare by offering generic medications ...

Nutrients in fish are beneficial for heart health, but fish high in purines can trigger a gout attack. Purines are important to the body, and when they break down, they form a substance called uric ...

Amgen today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology (ACR) Convergence 2024 conference in Washington, D.C., ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

The FDA has just dropped a truth bomb: if you’ve been relying on those familiar red pills for a stuffy nose, it might be time ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...

For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduction in recurrence.